Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Hélène Ansart Pirenne"'
Autor:
Emilie Le Toriellec, Vintuya Muralitharan, Philippe Chadebech, Alicia Jouard, Hélène Ansart‐Pirenne, France Pirenne, Christophe Tournamille, Laure Croisille
Publikováno v:
Transfusion
Transfusion, Wiley, 2020, 60 (11), pp.2482-2488. ⟨10.1111/trf.15980⟩
Transfusion, Wiley, 2020, 60 (11), pp.2482-2488. ⟨10.1111/trf.15980⟩
International audience; Background: CD36 glycoprotein is expressed by various cell types, including platelets (PLTs), monocytes, and erythroid precursors, and is also the receptor for several ligands. However, absence of CD36 expression seems asympto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48242c8532b6836ad03b055c47b1b77c
https://www.hal.inserm.fr/inserm-03238469
https://www.hal.inserm.fr/inserm-03238469
Autor:
Louise Pannetier, Marie Tamagne, Thibaut Bocquet, France Pirenne, Hélène Ansart‐Pirenne, Benoît Vingert
Publikováno v:
Transfusion
Transfusion, Wiley, 2020, Online ahead of print. ⟨10.1111/trf.16201⟩
Transfusion, Wiley, 2020, Online ahead of print. ⟨10.1111/trf.16201⟩
International audience; Background: Platelet (PLT) transfusions are an essential treatment for bleeding disorders. However, immunologic complications can occur, including alloantibody production against Class I HLA molecules. The principal source of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a05c85c395547c44a5856a3c3b6c44c5
https://pubmed.ncbi.nlm.nih.gov/33241556
https://pubmed.ncbi.nlm.nih.gov/33241556
Autor:
Justine Coombs, Latifa Ben Hassen, Mathieu Leclerc, Marie Tamagne, Louise Pannetier, Mehdi Khelfa, Adèle Delorme, Thibaut Bocquet, Sébastien Maury, France Pirenne, Hélène Ansart‐Pirenne, Benoît Vingert
Publikováno v:
Transfusion
Transfusion, Wiley, 2020, 60, pp.2807-2814. ⟨10.1111/trf.16116⟩
Transfusion, Wiley, 2020, 60, pp.2807-2814. ⟨10.1111/trf.16116⟩
International audience; Background: Patients with hematologic malignancies require prophylactic or curative platelet transfusions to prevent or treat bleeding. Treatments such as chemotherapy, radiotherapy, and hematopoietic stem cell transplantation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ac7f0d7e048d7d106886746faad2baa
https://www.hal.inserm.fr/inserm-03129762/document
https://www.hal.inserm.fr/inserm-03129762/document
Autor:
Mehdi Khelfa, Sébastien Maury, Mathieu Leclerc, Marie Tamagne, Hélène Ansart-Pirenne, France Pirenne, Benoît Vingert
Publikováno v:
Transfusion Clinique et Biologique. 28:S31
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1251de3590242d385423f17c1f023b41
https://doi.org/10.1016/j.tracli.2021.08.091
https://doi.org/10.1016/j.tracli.2021.08.091
Autor:
Philippe Bierling, Gerald Bertrand, Hélène Ansart-Pirenne, Cécile Kaplan, Florent Delbos, Laure Croisille
Publikováno v:
Transfusion. 56:59-66
BACKGROUND In Caucasians, fetal/neonatal alloimmune thrombocytopenia (FNAIT) is most frequently caused by maternal alloimmunization against the human platelet antigen HPA-1a. The most serious complication of severe FNAIT is intracranial hemorrhage (I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24b21939b27645d68088ee73f1e01e94
https://doi.org/10.1111/trf.13274
https://doi.org/10.1111/trf.13274
Autor:
Frédéric Galactéros, Marie Tamagne, Rahma Elayeb, Sadaf Pakdaman, Benoît Vingert, Julie Ripa, Hélène Ansart-Pirenne, Pablo Bartolucci, Philippe Bierling, Anoosha Habibi
Publikováno v:
European Journal of Immunology. 45:1868-1879
Alloimmunization against red blood cells (RBCs) is the main immunological risk associated with transfusion in patients with sickle cell disease (SCD). However, about 50-70% of SCD patients never get immunized despite frequent transfusion. In murine m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::878d2ac750eb9ee03271a71ae9d6e30a
https://doi.org/10.1002/eji.201445187
https://doi.org/10.1002/eji.201445187
Autor:
Louise Pannetier, Marie Tamagne, Justine Coombs, Thibaut Bocquet, France Pirenne, Hélène Ansart-Pirenne, Benoit Vingert
Publikováno v:
Transfusion Clinique et Biologique. 26:S85
La transfusion de concentres plaquettaires (CP) est le traitement preventif et/ou curatif indispensable du risque hemorragique. Ces transfusions peuvent induire une alloimmunisation anti-HLA Classe I pouvant aboutir dans certains cas a un etat refrac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b8e33f0868c215063f2d4e8fc8c2937
https://doi.org/10.1016/j.tracli.2019.06.174
https://doi.org/10.1016/j.tracli.2019.06.174
Autor:
Clara Ibanez, Hélène Ansart Pirenne, Arnaud Dupuis, Philippe Bierling, Laure Croisille, Emilie Le Toriellec
Publikováno v:
Transfusion Clinique et Biologique. 26:S65
Introduction Les Thrombasthenies de Glanzmann (GT), syndromes de Bernard et Soulier (BS), et patients deficitaires en GPIV/CD36 (CD36NEG) peuvent developper des isoanticorps apres transfusions ou grossesses. Le MAIPA est la technique de reference pou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6da9163fb3578940e38fce8f3b43922
https://doi.org/10.1016/j.tracli.2019.06.107
https://doi.org/10.1016/j.tracli.2019.06.107
Autor:
Justine Coombs, Marie Tamagne, Louise Pannetier, Rym Chouk Turki, Thibaut Bocquet, Sébastien Maury, France Pirenne, Hélène Ansart-Pirenne, Benoit Vingert
Publikováno v:
Transfusion Clinique et Biologique. 26:S98
Les transfusions plaquettaires sont souvent indispensables chez les patients thrombopeniques ou thrombopathiques Ces transfusions peuvent induire une alloimmunisation anti-HLA Classe I pouvant aboutir a un etat refractaire. A ce jour, les mecanismes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f00d24b48e2f3773497ae505e16d7d85
https://doi.org/10.1016/j.tracli.2019.06.211
https://doi.org/10.1016/j.tracli.2019.06.211
Publikováno v:
Transfusion Clinique et Biologique. 26:S97
Introduction Les thrombopenies immunologiques induites par des medicaments (TIMD) sont rares, mais profondes, survenant brutalement apres l’administration d’un medicament auquel le patient a ete prealablement expose de facon repetee. De nombreux
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1bc686c6fa6e9c04dafa9314301b2028
https://doi.org/10.1016/j.tracli.2019.06.209
https://doi.org/10.1016/j.tracli.2019.06.209